June, 2016

• IU launches $120 million initiative to cure and prevent Multiple Myeloma, Triple Negative Breast Cancer, and Childhood Sarcoma
• Kun Huang, PhD recruited as Data & Informatics Pillar Leader
• Precision Genomics clinics expand to four locations beyond Indianapolis
• Michael Weiss, MD, PhD recruited as Chemical Biology &Biotherapeutics Pillar Leader
• First Good Manufacturing Practice Cell Therapy Lab opens on campus
• IU acquires largest genome sequencing capabilities in the Midwest
• Researchers identify Alzheimer’s Disease & Type 2 Diabetes as diseases they are working to prevent
• $80 million of $120 million already committed to cures & prevention

2018 Today and Soon

• Our partner IU Health administers CAR T-Cell Therapy to its first adult patient
• Pediatric patients expected to receive CAR T-Cell Therapy as early as this fall at Riley Hospital for Children at IU Health
• First IU Precision Health study wraps up in Triple Negative Breast Cancer
• Person to Person Health Interview Study kicks off in rural Indiana